Cenegenics Improves Operational Efficiency with Domo
20 Junho 2024 - 5:05PM
Business Wire
Domo (Nasdaq: DOMO) announced today that Cenegenics, a leader in
the performance health technology industry, now uses its
cloud-native data and analytics platform to improve patient care
through real-time insights, accessible data and optimized
inventory.
Cenegenics helps patients achieve their peak cognitive, physical
and metabolic health by leveraging data from various biomarkers.
Just as patients use Cenegenics to enhance their health, Cenegenics
needed more real-time visibility into its business performance.
Information was siloed in disconnected systems, meaning analysts
spent weeks manually gathering and analyzing data. With Domo,
Cenegenics now has complete, real-time data and insights into
operations at individual clinics, delivering the visibility the
business needs to compete in a quickly-evolving space.
“Before we implemented Domo at Cenegenics, it could take months
to get access to important data we needed such as revenue and
patient retention,” said Roxana Boboescu, Director of Business
Intelligence at Cenegenics. “Our focus wasn’t just about getting
the right data, but it was about getting it at a speed that allowed
us to quickly recognize factors in our business that weren't
working and make timely changes that help give us a competitive
edge.”
Cenegenics also utilizes Domo to monitor and improve the patient
experience. For example, the company can see patient responses to
communications across text, phone calls and email, and then tailors
message efforts via the channels that drive better engagement. The
company can also analyze which products and services are most
widely used across physicians and locations. Through a better
understanding of how each physician uses specific products,
Cenegenics can order exactly what it needs when it needs it,
allocating resources accordingly and ultimately reducing its
inventory costs.
The company uses Domo to measure each clinic’s progress across
core KPIs, giving executives, physicians and coaches the ability to
compare performance over time periods and locations, and equipping
them with all the resources needed to make improvements. In its
first year using Domo, Cenegenics has brought its health-optimizing
technology to a broader audience, increasing its client count by
16%, signups by 11% and revenue by 10%.
“Cenegenics demonstrates how improved data experiences can
translate to tangible, real-world benefits,” said Mark Maughan,
chief analytics officer and SVP of customer success, Domo. “When
you have the ability to provide real-time updates and make data
accessible, not only do organizations see a positive business
impact, but their customers feel it too. With Cenegenics, that
means there are people who are performing better.”
To learn more about how innovative organizations like Cenegenics
are using Domo to put data to work for everyone, visit
www.domo.com/customers.
About Domo
Domo puts data to work for everyone so they can multiply their
impact on the business. Our cloud-native data experience platform
goes beyond traditional business intelligence and analytics, making
data visible and actionable with user-friendly dashboards and apps.
Underpinned by AI, data science and a secure data foundation that
connects with existing cloud and legacy systems, Domo helps
companies optimize critical business processes at scale and in
record time to spark the bold curiosity that powers exponential
business results.
For more information, visit www.domo.com. You can also follow
Domo on LinkedIn, X and Facebook.
Domo is a registered trademark of Domo, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240620392203/en/
Cynthia Cowen PR@domo.com
Domo (NASDAQ:DOMO)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Domo (NASDAQ:DOMO)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024